A guide framework for positioning an ultrasonic transducer which emits a focused ultrasound to a target point in carrying out surgery to apply ultrasonic stimulation to a subject's brain, includes a body in a shape of a mask that is laid on the subject's face, and a positioning hole formed through an inner surface and an outer surface of the mask body, the positioning hole into which the ultrasonic transducer is inserted, wherein the inner surface of the mask body is formed to conform a facial contour of the subject, and when the guide framework is laid on the subject's face and the ultrasonic transducer is disposed at the positioning hole, the position of the target point is naturally disposed at a preset stimulation site of the brain. An ultrasonic stimulation device includes an ultrasonic transducer and the guide framework for positioning the ultrasonic transducer.

A system and method for planning surgical procedure including a treatment zone setting view presenting at least one slice of a 3D reconstruction generated from CT image data including a target. The treatment zone setting view presenting a treatment zone marker defining a location and a size of a treatment zone and configured to adjust the treatment zone marker in response to a received user input. The system and method further including a volumetric view presenting a 3D volume derived from the 3D reconstruction and a 3D representation of the treatment zone marker relative to structures depicted in the 3D volume.

A system and method for planning surgical procedure including a treatment zone setting view presenting at least one slice of a 3D reconstruction generated from CT image data including a target. The treatment zone setting view presenting a treatment zone marker defining a location and a size of a treatment zone and configured to adjust the treatment zone marker in response to a received user input. The system and method further including a volumetric view presenting a 3D volume derived from the 3D reconstruction and a 3D representation of the treatment zone marker relative to structures depicted in the 3D volume.

A biomechanical optimization (BMO) prosthetic implant utilizes a thin cross-section of metallic material that is conformable. Preferably, the BMO prosthetic implant is conformable both at the time of implant in response to manipulation and fixation by the surgeon, as well as during the life of the implant in response to stresses and loads experienced by the implant and thereby communicated and responded to by living bone tissue. For most metallic alloys, the BMO prosthetic implant will have an effective cross-sectional thickness of 4 mm or less, and preferably 3 mm or less. In one embodiment, the BMO prosthetic implant is provided with one or more fins extending from the fixation surface(s) of the implant which preferably includes retaining structures, such as cross-pinned apertures or T-shaped edge ridge.

A biomechanical optimization (BMO) prosthetic implant utilizes a thin cross-section of metallic material that is conformable. Preferably, the BMO prosthetic implant is conformable both at the time of implant in response to manipulation and fixation by the surgeon, as well as during the life of the implant in response to stresses and loads experienced by the implant and thereby communicated and responded to by living bone tissue. For most metallic alloys, the BMO prosthetic implant will have an effective cross-sectional thickness of 4 mm or less, and preferably 3 mm or less. In one embodiment, the BMO prosthetic implant is provided with one or more fins extending from the fixation surface(s) of the implant which preferably includes retaining structures, such as cross-pinned apertures or T-shaped edge ridge.

A probe insertion device for implanting a probe into tissue includes a rigid base that selectively attaches to the probe due to a bond between the base and the probe, that provides a structural backbone to the probe, is longitudinally aligned with the probe, and can be adapted to receive a fluid between the base and the probe. The probe insertion device can include a surface covering at least a portion of the base that reduces the bond between the base and the probe in the presence of the fluid.

An implant positioning device is fitted on to an orthodontic brace of a patient and used in between an X-ray projecting machine and an X-ray film. The implant positioning device includes a measuring standard member, that forms a detection region by means of a radiopaque material and has a positioning unit on one side of the detection region. The detection region is provided with at least one set of measuring scales. An encircled member is integrated with one side of the measuring standard member and forms an encircling main body that is connected to the orthodontic brace. A sleeved space is collectively formed by the encircling main body and the measuring standard member.

A surgical apparatus for positioning within a tissue tract accessing an underlying body cavity is adapted to articulate instruments inserted therein. The surgical apparatus includes an anchor member configured to form a sealing relation with a tissue, a balloon member and a plurality of articulating arms extending distally from the anchor member. Inflating and/or deflating the balloon member effectuate articulation of the articulating arms.

A surgical apparatus for positioning within a tissue tract accessing an underlying body cavity is adapted to articulate instruments inserted therein. The surgical apparatus includes an anchor member configured to form a sealing relation with a tissue, a balloon member and a plurality of articulating arms extending distally from the anchor member. Inflating and/or deflating the balloon member effectuate articulation of the articulating arms.

Methods for treating a human patient having a subarachnoid hematoma, such as to prevent cerebral vasospasm or to reduce the severity of cerebral vasospasm in the patient, and associated devices, systems, and methods are disclosed herein. In a particular embodiment, a thrombolytic agent is introduced extravascularly into a subarachnoid region including the hematoma. A headset configured for hands-free delivery of transcranial ultrasound energy is connected to the patient and used to deliver ultrasound energy to the subarachnoid region to enhance the thrombolytic effect of the thrombolytic agent. The type and/or dosage of the thrombolytic agent can be selected based on the enhanced thrombolytic effect. For example, the enhanced thrombolytic effect can allow the therapeutically effective use of less aggressive thrombolytic agents and/or lower dosages of thrombolytic agents. In some cases, this can reduce the clinical probability of additional cerebral hemorrhage.